Ultrastructural features of intercellular contacts in pancreatic insulinomas



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Insulinomas are the most frequent functional pancreatic neuroendocrine tumors. To study the ultrastructural structure intercellular contacts of insulinomas G1-2. Material about tumors of 38 patients who had been in the surgical treatment from 2010 to 2015 was studied. Male to female ratio was 38:62 (10/28). The age range differed from 23 to 71 y.o. The average age was 48.2 years. All the patients had the symptoms of hyperinsulinism determined. In 39% (1 5/38) the MEN syndrome was revealed. All the tumors were clinically benign. The electron and histological study of the removed tumors was conducted. In 39,5% (15/38) the tumor was localized in the head, in 24% - in the tail, in 21% - in the body, and in 5% - in the isthmus. In two cases the lesion affected the body and the tail of the gland (5%), and in another two - it affected the whole gland (5%). Tumor nodule size ranged from 0.8 to 5.5 cm. The average size was 2.0 cm. G1 was present in 84%. G2 was present in six cases. The tumors were composed of monomorphic cells with a low nucleus-cytoplasmic ratio and abundant eosinophilic cytoplasm. Two main ß-cell phenotypes in different stages of functional activity were detected. The first type of cells was “the light cells», which were dominated by the processes of synthesis of granules. The second type was “the dark cells», in which the processes of hormone secretion outside the cell membrane were actively running. The two cell types were connected by the desmosomal junctions. In the area of contact of adjacent cells' cytomembrane the portions of the cytoplasmic fusion with the formation of cytoplasmic bridges were determined. This resulted in the formation of syncytium-like structures. These changes were more common between “the light cells”. Through the cytoplasmic bridges the metabolic processes of nutrients and secretory material occure. Perhaps, it is a condition for the release of granules synchronization processes in the bloodstream, which may explain the cause of hypoglycemic crises. Syncytium-like structure due to the large size cannot penetrate through the fenestrated capillary, eliminating the possibility of the formation of the secondary tumors. Moreover, their production makes it impossible to complete the next cell division. Progression of the tumor stops. The formation of syncytium-like structures may be one of the causes of a conservation of a benign potential in insulinoma.

Full Text

Restricted Access

About the authors

E. N Gordienko

A.V. Vishnevsky Surgery Institute; S.P. Botkin City Clinical Hospital

Email: gordienko119@mail.ru

I. A Chekmareva

A.V. Vishnevsky Surgery Institute

O. V Paklina

A.V. Vishnevsky Surgery Institute; S.P. Botkin City Clinical Hospital

A. G Kriger

A.V. Vishnevsky Surgery Institute

A. R Kaldarov

A.V. Vishnevsky Surgery Institute

I. V Laricheva

Central Research Institute of Health Organization and Informatization

References

  1. Keutgen X.M., Nilubol N., Kebebew E. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis. Surgery 2015; 159(5): 1382-9.
  2. Whipple A.O., Frantz V.K. Adenoma of islet cells with hyperinsulinism: a review. Ann. Surg. 1935; 101(6): 1299-335.
  3. Delellis R.A. The neuroendocrine system and its tumors: an overview. Am. J. Clin. Pathol. 2001; 115: 5-16.
  4. Yamashita Y., Okuzono Y., Yokota T. et al. Morphologic study of three cases of insulinoma. Histochemical an ultrastructural studies. Cancer 1985; 55(4): 841-7.
  5. Richards O.C., Raines S.M., Attie A.D. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr. Rev. 2010; 31(3): 343-63.
  6. Ueda K., Taira T., Hakoda H. et al. Giant insulinoma: report of a case and review of published reports. Surg. Case Rep. 2016; 2: 136.
  7. lelpo B., Caruso R., Ferri V. et al. Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review. Int. J. Surg. Case Rep. 2013; 4(3): 265-8.
  8. Vasikasin V., Watthanatham J., Napatharatip P. et al. Giant insulinoma in a 15-year-old man: A case report. Int. J. Surg. Case Rep. 2016; 24: 135-8.
  9. Creutzfeldt W., Arnold R., Creutzfeldt C. et al. Biochemical and morphological investigations of 30 human insulinomas. Diabetologia 1973; 9(3): 217-31.
  10. Herder W.W., Niederle B., Scoazec J. et al. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006; 84: 183-8.
  11. Morin E., Cheng S., Mete O. et al. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior. Cancer Med. 2013; 2(5): 701-11.
  12. Нефедова Н.А., Харлова О.А., Данилова Н.В. и др. Маркеры ангиогенеза при опухолевом росте. Ж. Архив патологии 2015; 2: 55-62.
  13. Su T., Wang Y., Wang J. et al. In vivo magnetic resonance and fluorescence dual-modality imaging of tumor angiogenesis in rats using GEBP11 peptide targeted magnetic nanoparticles. J. Biomed. Nanotechnol. 2016; 12(5): 1011-22.
  14. Na H., Liu X., Li X. et al. Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis. J. Hematol. Oncol. 2017; 10(1): 28.
  15. Mirancea G.V., Morosanu A.M., Carniciu S. et al. Relevant infrastructural alterations in a pancreatic neuroendocrine tumor: an insulinoma case. Rom. J. Morphol. Embryol. 2014; 55 Suppl 2: 659-68.
  16. Афанасьев Ю.И., Юрина Н.А., Котовский Е.Ф. Половая система. В: Афанасьев Ю.И., Юрина Н.А., редакторы. Гистология, эмбриология, цитология. 5-е изд. М.: Медицина; 2001. c. 679-82.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies